Loading the records…
Loading the records…
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
National Institutes of Health is planning to buy "Liquid Chromatography System". This is an early notice: it is not taking bids yet. The work is in MD, USA. Responses are due Nov 28, 2026. In the last 2 years, similar work went to 10 or more companies, usually for about $143K per award. An award is expected between December 2026 and September 2027.
Put together from the facts on this page; the details and sources are below.
Your briefs and their views: My briefs.
Every notice posted under solicitation PCA-NIDDK-12835 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
, is required for monitoring the completion of chemical reactions involved in protein production and for verifying the purity of the final products. This instrument requires periodic maintenance, calibration and frequent repairs to replace worn-out or failed components. The objective of this requirement is to ensure that the liquid chromatography-mass spectrometry instrument continues to operate according to its specifications, so that research projects that depend on this instrument can continue to make rapid progress The service contract must cover all components of the LC-MS instrument, including an ISQEM Mass Spectrometer, an Ultimate 3000 LPG-3400SD Low Pressure Mixer, an Ultimate 3000 WPS-3000TSL analytical autosampler, an UltiMate 3000 TCC-3000SD Thermostatted Column compartment, an Ultimate 3000 VWD-3400RS variable wavelength detector, and computer that controls the system. � The service contract must include one annual preventive maintenance visit, during which a technician will test and calibrate all components, replace all parts that require periodic replacement, and perform relevant software upgrades. � The service contract must cover labor, travel, and parts costs for repairs, with a 3-business-day response time. � The service contract must include immediate technical support over the phone or internet when users of this instrument encounter problems or have questions. The vendor shall perform annual preventive maintenance once during the period of performance, on a date requested by users of the LC-MS instrument. The vendor shall provide immediate technical support to users when any problems arise, over the phone or the internet. If a problem can not be resolved remotely, the vendor shall send a service engineer or technician with appropriate expertise to repair the LC-MS instrument within three business days of the initial contact. All costs of labor, travel, and parts will be covered by the service contract, with no additional charges. The Project Officer is responsible for: (1) monitoring the Contractor's technical progress, including the surveillance and assessment of performance and recommending to the Contracting Officer changes in requirements; (2) interpreting the statement of work and any other technical performance requirements; (3) performing technical evaluation as required; (4) performing technical inspections and acceptances required by this Purchase Order; and (5) assisting in the resolution of technical problems encountered during performance. The Contracting Officer is the only person with authority to act as agent of the Government under this Purchase Order. Only the Contracting Officer has authority to: (1) direct or negotiate any changes in the statement of work; (2) modify or extend the period of performance; (3) change the delivery schedule; (4) authorize reimbursement to the Contractor any costs incurred during the performance of this Purchase Order; or (5) otherwise change any terms and conditions of this Purchase Order.
15 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same NAICS 811210.
Single-winner award sizes (15): middle half $45K to $211K, median $143K; range $18K to $16.1M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BRUKER BIOSPIN CORP · $BRKR · $3.5B | 2 | $329K | Jul 30, 2026 |
| BECTON, DICKINSON AND COMPANY · $BDX · $22.5B | 2 | $291K | Jan 26, 2026 |
| ENV Services Inc | 1 | $16.1M | Feb 6, 2026 |
| Revvity Health Sciences, Inc. | 1 | $696K | Sep 24, 2025 |
| MOLECULAR DEVICES LLC | 1 | $236K | Nov 22, 2024 |
| CTF MEG NEURO INNOVATIONS INC | 1 | $185K | Sep 9, 2025 |
| ETS-LINDGREN INC · $ESE · $1.3B | 1 | $157K | Sep 10, 2025 |
| HAMILTON COMPANY | 1 | $124K | May 6, 2025 |
| NANOCELLECT BIOMEDICAL INC | 1 | $58K | Mar 20, 2025 |
| ABBERIOR INSTRUMENTS AMERICA LLC | 1 | $46K | Dec 11, 2024 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
None of these past winners filed lobbying reports naming Natl Institutes of Health (NIH) since 2024. No sign of an incumbent lobbying push at this agency.
No lobbyist on these filings lists a past Natl Institutes of Health (NIH) job: no revolving-door tie found in these filings. (These are lobbyists the companies pay, not their own staff.)
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
No bills named on these filings under National Institutes of Health-related issues.
A bill's title is shown only when the filing's own text names it; filings often cite last Congress's bill numbers.
No rules or proposed rules from the department in the last 12 months.
No executive order in the last 12 months names National Institutes of Health in its title or summary.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.